Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)

Name: Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Published: 2024
License: Public Domain

IRCCS Azienda Ospedaliero-Universitaria di Bologna · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

marginal zone lymphoma(mzl), zanubrutinib, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)

Related documents